|Description||ABT-639, a new blocker of selective T-type Ca2+ channel blocker, has been found to have potential effect against neuropathic and nociceptive pain in studies. It has already been discontinued in the treatment of diabetic neuropathies.|
|B0084-474418||300 mg||$688||In stock|
|Synonyms||ABT-639; ABT 639; ABT-639 free base; UNII-0G7D0CQ88I; SCHEMBL400073; 0G7D0CQ88I|
|Solubility||DMSO: ≥ 10 mg/mL|
|Application||ABT-639 is a new blocker of selective T-type Ca2+ channel blocker that has been found to have potential effect against neuropathic and nociceptive pain in studies.|
|Shelf Life||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly|
Evenamide is a selective voltage-gated sodium and/or calcium channel modulator, including subtypes Nav1.3, Nav1.7, and Nav1.8. It may be potentia useful in pre...
NP-118809 is a N-type calcium channel blocker exhibits both anti-allodynic and anti-hyperalgesic activity in the spinal nerve ligation model of neuropathic pain...
Amlodipine maleate is a long-acting dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker). It inhibits the movement of calcium ion...
Watanipidine, also called as AE 0047 or Calbren, is a calcium channel antagonist.
Nicardipine is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders.
Huwentoxin XVI is a potent and selective N-type Ca2+ channel blocker (IC50 ~ 60 nM) with no inhibitory effect on T-type Ca2+ channels, K+ channels or Na+ channe...
PD 173212 is a potent N-type voltage-gated calcium channel blocker (IC50 = 36 nM), with selectivity over K+, Na+ and L-type Ca2+ channels. Selective N-type volt...
Fluspirilene, with antipsychotic activity, is a non-competitive antagonist of agonist-activated L-type calcium channels (IC50 = 0.03 µM). Fluspirilene is also a...